An AI-enabled biotechnology company focused on aging intervention and longevity drug discovery
An AI-enabled biotechnology company focused on aging intervention and longevity drug discovery. Its proprietary H2P model aims to improve translation of mouse-study findings to human applications, while pet health provides an early commercialization path for validating product value with lower clinical and ethical risk.